In CLL, BTK-Inhibitor Resistance Remains a Confounding Problem
AJMC,
The development of Bruton’s tyrosine kinase (BTK) inhibitors has led to a paradigm shift in the treatment of chronic…
Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL)
Overview of attention for article published in Genes, December 2023
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (87th percentile)
-
High Attention Score compared to outputs of the same age and source (93rd percentile)
Readers on
- mendeley
- 23 Mendeley